GlassScriptPhysician profile
Jeff Pettey
NPI 1346494911
$19,089.24
in general payments reported to CMS, 2019-2025
11 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,865 · 2021: $4,755 · 2022: $3,203 · 2023: $5,255 · 2024: $794 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,775 · Food and Beverage: $866 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,775.00 |
| Food and Beverage | $865.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $625.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $6,341.80 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $5,046.85 | 2019-2023 | Tecnis Simplicity |
| Carl Zeiss Meditec, INC. | $3,174.41 | 2023 | Veracity Surgical, Quatera 700, Visumax |
| Alcon Vision LLC | $1,926.76 | 2019-2025 | Centurion, Unity, Clareon |
| Abbvie INC. | $1,488.76 | 2022 | |
| Bausch & Lomb Americas INC. | $625.00 | 2024 | Envista Mx60 Iol, Miebo, Xiidra |
| Carl Zeiss Meditec USA, INC. | $199.29 | 2021-2024 | Quatera 700 |
| New World Medical,INC. | $121.67 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $115.47 | 2024 | Tecnis Simplicity |
| Dutch Ophthalmic, USA | $26.34 | 2025 | Eva, Combined Machine, Tissueblue |
| Sight Sciences, INC. | $22.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Pettey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.